Breaking News

NEJM, public health group are launching rival to CDC’s MMWR

October 21, 2025
Adobe

NEJM and public health group are launching rival to CDC's MMWR publication

With confidence slipping in the CDC's Morbidity and Mortality Weekly Report, NEJM and CIDRAP will begin publishing rival journal

By Anil Oza


Nursing facilities can't blanket ban people with addiction history, per N.C. settlement

Settlement may open doors for people with addiction to enter long-term care, signaling a possible legal shift in addiction treatment access.

By Lev Facher


STAT+ | AMA wades into turbulent debate over AI regulation with new digital health center

American Medical Association announces new Center for Digital Health and AI to influence how novel technology is regulated: A Q&A with AMA CEO John Whyte.

By Mario Aguilar



Mikhail
Photo by Jeff Pinette

YouTuber 'Doctor Mike' thinks medicine needs a better social media strategy

Trust in public health institutions has been declining for years. This physician has some ideas to fix that

By Alex Hogan


STAT+ | Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs

ADAPs provided recent utilization data to Gilead so the company could better understand how price hikes would financially strain the programs

By Ed Silverman


STAT+ | Effort to guide treatment of cancer with novel blood tests may get boost from new research

New data from Europe suggest Natera's Signatera ctDNA blood test can reveal which cancer patients need more therapy and who may already be cured.

By Andrew Joseph


ELSA RANCEL/AFP via Getty Images

Opinion: CMS says it's cutting fraud. Patients like me may pay the price with our lives

CMS's new policy means limited product availability, fewer suppliers, delivery delays, and a higher risk of medical emergencies.

By Ali Ingersoll


Opinion: The origins of Covid and public health's uncertainty problem

We're teaching our public health graduate students about the Covid origin debate to equip them for the future

By Michaela Kerrissey and Richard J. Tofel


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments